In recent years, antibody therapies have seen rapid advancements, becoming pivotal treatments for cancer, infectious diseases, and autoimmune disorders. Innovations such as monoclonal antibodies (mAbs ...

Developers can use insights from this research to inform buffer selection and experimental design, even without building a separate model.

Recent advancements in monoclonal antibody engineering are reshaping disease treatment, focusing on safety, effectiveness, ...

ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA,” the “Company,” or “we”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today ...

Identification of the AAV receptor and vector-specific reagents has led to the development of purification protocols for rAAV vectors by affinity (receptor/antibody) matrix chromatography.

Likewise, it is unknown to what extent antibody responses to different citrullinated proteins are cross-reactive. The authors established an affinity purification method in which citrullinated-antigen ...

Researchers identified a unique antibody signature against the Epstein-Barr virus protein EBNA1 that correlates with cross-reactive immune responses in multiple sclerosis (MS) patients.

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).